Nihat Buğra Ağaoğlu

Associate Professor of Medical Genetics - Cancer geneticist / BJK Congress Member 🦅

[Beşiktaş JK @Besiktas]

Bayrak inmez! 🇹🇷

[Beşiktaş JK @Besiktas]

#12DevAdam Finalde! 💪

Adım adım Avrupa Şampiyonluğuna. 😎

Sizinle gurur duyuyoruz. 🇹🇷

[OncoDaily @oncodaily]

Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes

https://t.co/8sLdR29OfV

@DFCI_BreastOnc @JAMANetworkOpen @DrBBychkovsky @nbagaoglu @judygarber5 @DrHQRana

#Cancer #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

[Nihat Buğra Ağaoğlu @nbagaoglu]

It's a great pleasure to be a part of this wonderful team at @DanaFarber

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

Check out this recent @JAMANetworkOpen on Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes
🔓https://t.co/kF35qoCq6X
@DrBBychkovsky @nbagaoglu @judygarber5 @DrHQRana

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

Check out this recent @JAMANetworkOpen on Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes
🔓https://t.co/kF35qoCq6X
@DrBBychkovsky @nbagaoglu @judygarber5 @DrHQRana

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

Dr. Judy Garber (@judygarber5) shared updated OlympiA Phase 3 trial results in today's #SABCS24 General Session #olaparib #BRCA1 #BRCA2 #BreastCancer

[Brittany Bychkovsky, MD @DrBBychkovsky]

Collaborative project with @nbagaoglu @DrHQRana and @unl_xo and many others is now out in Cancers. This work characterizes CHEK2 variants detected among individuals who underwent genetic testing in Turkey. See: https://t.co/7FL83hknr8

[Dana-Farber @DanaFarber]

Do cancers always have a genetic component?

Huma Rana, MD, MPH, clinical director of Cancer Genetics and Prevention at Dana-Farber, explains how 15% of cancers are linked to inherited mutations. https://t.co/KavvN95Ho6

[Beşiktaş JK @Besiktas]

İmzanı attığın Cumhuriyetin ilelebet bekçisiyiz. ∞

Cumhuriyetimizin kurucusu Ulu Önder Gazi Mustafa Kemal Atatürk'ü saygı, minnet ve özlemle anıyoruz.

[Nihat Buğra Ağaoğlu @nbagaoglu]

Excited to announce I'll speak at the IBG Izmir Biomedicine and Genome Center seminar! My talk will cover our team's unique insights into #HereditaryCancer🔬
📅 Date: 20.09.2024 | 11:00
📍 Location: IBG Izmir Biomedicine and Genome Center, Aziz Sancar Auditorium
@RareDiseasesIBG

[Ambry Genetics @AmbryGenetics]

What happens when #hereditarycancer testing identifies two pathogenic variants? We compared cancer risk in >600 individuals with double PVs to those with a single PV in this publication with @DanaFarber. https://t.co/cwrWgLkuWz #genechat #genechatpubs @nbagaglu @DrBBychkovsky

[Genetics in Medicine @GIMJournal]

Insights of #cancer burden from a large retrospective study: patients with double pathogenic variants in cancer predisposition genes showed greater burden than those with single gene variants https://t.co/EkRtw2VYI6 @DrHQRana #GIMO #MultiplePathogenicVariants #BreastCancer

[Nihat Buğra Ağaoğlu @nbagaoglu]

Our study at the @DanaFarber has been recently published in @GIMJournal Open! It is such a pleasure to be a member of the @DanaFarber Cancer Genetics&Prevention family and to work with the @AmbryGenetics team! #hereditarycancer @carrieotype @DrBBychkovsky @DrHQRana @judygarber5

[Beşiktaş JK @Besiktas]

Adalet bir gün herkese lazım olacak!

“Bir oyuncuyu öldürdükleri gün veya en sevdiği şeyi yapmasını engelleyerek sakat bıraktıkları gün, ya da bir hakeme saldırdıkları gün beni hatırlayacaksınız.”

𝟬𝟰.𝟬𝟵.𝟮𝟬𝟮𝟮
Josef de Souza

Şiddete maruz kalan Halil Umut Meler’e geçmiş olsun dileklerimizi iletiyor, daha önce alınan kararların aksine; spor ile hiç bağdaşmayan bu eylemi yapanların en ağır şekilde cezalandırılmasını diliyor ve saldırıyı gerçekleştirenleri kınıyoruz.

[Ambry Genetics @AmbryGenetics]

Ambry talked with Dr. Huma Q. Rana about her Journal of Clinical Oncology article. She says, “It is imperative to identify service delivery models to help us meet the increasing demand for timely access to genetic testing.” Check out the full article: https://t.co/jYhN92TX0a

[Nihat Buğra Ağaoğlu @nbagaoglu]

@odatv da ayrı olacak nasıl gazetecisiniz 🤷🏻‍♂️

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

Congratulations @DrBBychkovsky and colleagues on your @JAMAOnc publication examining "Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2" #BreastCancer #bcsm

[Nihat Buğra Ağaoğlu @nbagaoglu]

Andrew Binns
@EACRnews
🙏🏻🙏🏻🙏🏻